Hospira to Present at Upcoming Investor Conferences

LAKE FOREST, Ill., Aug. 14, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company will present at the following upcoming conferences:

  • Morgan Stanley Global Healthcare Conference
    Sept. 11, 2012 (Tuesday) – New York
    10:55 a.m. Eastern time

  • UBS Global Life Sciences Conference
    Sept. 19, 2012 (Wednesday) – New York
    11:00 a.m. Eastern time

The presentations will be available to all interested parties through live audiocasts accessible via the investor relations section of Hospira's website at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocasts.  A replay of the webcasts will be available on the Hospira website approximately 24 hours after each live presentation for 30 days after each event.

About Hospira
Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 15,000 employees. Learn more at www.hospira.com.

SOURCE Hospira, Inc.